London Cancer Hub: £1bn New Campus Gets Green Light

A £1 billion development to create a world-leading cancer research district in Sutton, South London, has moved a step closer to reality, with plans submitted to the London Borough of Sutton. The project, known as The London Cancer Hub, aims to bring together academic researchers, clinicians and life sciences companies to accelerate innovation in cancer research and treatment.

The development, unveiled by Aviva Capital Partners (ACP) and mixed-use developer Socius, will deliver approximately one million square feet of state-of-the-art research and laboratory space. It builds upon existing infrastructure at The London Cancer Hub, which already houses The Institute of Cancer Research (ICR) and The Royal Marsden NHS Foundation Trust’s Sutton treatment centre. The scheme is expected to accommodate a range of tenants, from large pharmaceutical companies to start-ups, with facilities for wet labs, Good Manufacturing Practice (GMP) facilities, and specialist equipment.

The project’s scale and ambition were highlighted by Councillor Barry Lewis, leader of the London Borough of Sutton, who stated that The London Cancer Hub will position Sutton as London’s global centre for oncology. He further noted that the site is already recognised as a leading life science cluster in the capital, with its strength lying in the current delivery of world-class cancer research, discoveries, and treatment all within a single location.

Beyond research facilities, the development will incorporate a range of amenities designed to attract and support talent. These include restaurants and cafes, a creche, and affordable homes for approximately 220 key workers. A ‘Learning Lab’, comprising classroom and educational spaces, is also planned to inspire the next generation to pursue careers in science and technology. The developers are aiming for net-zero carbon in operation, exceeding mandatory sustainability and energy efficiency standards.

The plans, submitted in May 2025, involve a series of buildings up to nine storeys in height on a 12-acre site. Aviva and Socius are hoping for a planning committee date in Autumn 2025, with construction scheduled to begin in 2026. The project team includes structural engineer Arup and planning consultant Savills.

The London Cancer Hub has been identified as a key district for frontier innovation by London Mayor Sadiq Khan, underscoring its strategic importance to the city’s research and development ecosystem. The development represents a significant investment in the UK’s life sciences sector and its capacity for cancer research.

The ICR welcomed the plans, recognizing the potential to foster collaboration between researchers at the ICR, clinicians at The Royal Marsden, and companies within the new development. This collaborative environment is intended to drive innovation and translate research findings into improved cancer treatments.

The project’s vision extends beyond immediate construction, with a 30-year plan to create a greener and healthier campus. Socius, one of the developers, emphasizes the importance of the power of place in fostering a thriving research community. This long-term perspective suggests a commitment to creating a sustainable and impactful hub for cancer research and treatment for decades to come.

The development’s design incorporates elements intended to create a supportive environment for patients and researchers alike. Drawing inspiration from facilities like the Maggie’s Centre at Charing Cross Hospital, the new campus aims to prioritize human-centred design, offering spaces that promote well-being and collaboration. This focus on creating a sanctuary-like atmosphere contrasts with the often clinical environment of traditional hospitals.

The £1 billion investment signifies a substantial commitment to advancing cancer research and treatment in the UK. The project’s success will depend on securing planning approval from the London Borough of Sutton and successfully attracting leading life sciences companies and researchers to the new facilities. The anticipated start of construction in 2026 will mark a significant milestone in the development of The London Cancer Hub as a global centre for oncology.